Skip to main content
TipRanks
Go Ultimate75% OFF

Me Today Limited (MEE) AI Stock Analysis

NZ:MEE

Me Today Limited

(NZX:MEE)

Select Model
Rating:42Neutral
Price Target:NZD 0.06â–¼(-3.33% Downside)
Action:reiterated
Date:11/01/26

Overall score is held down primarily by weak financial performance (continued losses and persistent negative free cash flow despite FY2026 margin and balance-sheet improvement). Technicals add further pressure with a clear downtrend and negative momentum, while valuation is constrained by negative earnings and no dividend support.

Positive Factors
Gross Margin RecoveryThe substantial gross-margin recovery and narrower losses indicate that product mix, pricing, or cost management improved during FY2026. Although profitability remains negative, sustaining this improvement would strengthen unit economics and bring the company closer to a viable operating model.
Negative Factors
Persistent UnprofitabilityContinued operating and net losses show that the business has not yet achieved sustainable scale or profitable operations. Even with FY2026 improvement, persistent losses can consume equity, restrict reinvestment, and make future growth dependent on further cost or revenue gains.

Me Today Limited (MEE) vs. SPDR S&P 500 ETF (SPY)

-50%-25%0%25%50%75%100%125%150%NZ:MEE+1.69%SPY+4.27%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
NZD 3.63M
Dividend Yield
―
Average Volume (3M)
41.82K
Price to Earnings (P/E)
-2.0
Beta (1Y)
0.21
Revenue Growth
-12.36%
EPS Growth
79.80%
Country
NZ
Employees
20
Sector
Consumer Defensive
Sector Strength
62
Industry
Packaged Foods

Me Today Limited Business Overview & Revenue Model

Company Description

Based in Auckland, New Zealand, Me Today Limited, through its various subsidiaries, is dedicated to the creation, distribution, and promotion of health and wellness products. The company offers a comprehensive range of dietary supplements designed to...

Me Today Limited Financial Statement Overview

Summary

Financial quality remains weak: the business is still unprofitable with negative operating profit and net income, and operating/free cash flow are negative across all years shown. Positives include a sharp FY2026 improvement vs FY2025 (losses narrowed and gross margin rebounded to ~51%) and a materially cleaner balance sheet (equity back to positive and debt much lower), but revenue fell ~31% in FY2026 and ongoing cash burn keeps funding risk elevated.

Income Statement

18Very Negative

Balance Sheet

34Negative

Cash Flow

20Very Negative
Financial statement breakdown
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Mar 2022
Income Statement
Total Revenue9.80M6.53M7.45M4.33M6.62M7.88M
Gross Profit4.91M3.31M1.51M4.33M1.65M2.03M
EBITDA-1.92M-1.31M-4.70M-4.11M-4.00M-4.57M
Net Income-154.00K-1.48M-6.02M-11.28M-15.64M-12.97M
Balance Sheet
Total Assets7.33M7.33M15.20M21.46M39.46M26.95M
Cash, Cash Equivalents and Short-Term Investments1.83M1.83M1.26M2.84M5.37M913.00K
Total Debt2.57M2.57M15.86M15.80M13.59M13.24M
Total Liabilities4.82M4.82M17.54M17.86M15.36M15.02M
Stockholders Equity2.51M2.51M-2.34M3.61M24.10M11.93M
Cash Flow
Free Cash Flow-2.14M-1.47M-1.54M-3.16M-12.43M-5.98M
Operating Cash Flow-2.10M-1.45M-1.54M-3.11M-12.11M-5.93M
Investing Cash Flow-232.50K-155.00K44.00K357.00K-17.46M1.25M
Financing Cash Flow3.17M2.16M-147.00K4.68M33.74M295.00K

Me Today Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price0.06

Price Trends

50DMA0.09Negative
100DMA0.07Negative
200DMA0.06Negative

Market Momentum

MACD-0.01Negative
RSI11.09Positive
STOCH0.00Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NZ:MEE, the sentiment is Negative. The current price of 0.06 is below the 20-day moving average (MA) of 0.07, below the 50-day MA of 0.09, and below the 200-day MA of 0.06, indicating a bearish trend. The MACD of -0.01 indicates Negative momentum. The RSI at 11.09 is Positive, neither overbought nor oversold. The STOCH value of 0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NZ:MEE.

Me Today Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

NZ:MEE against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
NZ:CVTNZ:CVT68NeutralNZD 98.69M7.619.98%―10.67%―
NZ:PHLNZ:PHL63NeutralNZD 33.62M0.03――15.19%1154.17%
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
NZ:BLTNZ:BLT61NeutralNZD 31.98M48.00――16.01%-28.57%
NZ:TAHNZ:TAH58NeutralNZD 37.83M11.70―4.15%21.56%18.96%
NZ:MEENZ:MEE42NeutralNZD 6.52M-2.03――-12.36%79.80%
NZ:RUANZ:RUA42NeutralNZD 11.77M-2.60――70.82%41.04%

* Consumer Defensive Sector Average

Performance Comparison

0%50%100%NZ:MEENZ:CVTNZ:BLTNZ:PHLNZ:TAHNZ:RUADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
NZ:MEE and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
NZ:MEEMe Today Limited0.060.001.69%
NZ:CVTComvita 0.760.2651.09%
NZ:BLTBLIS Technologies Limited0.020.0160.00%
NZ:PHLPromisia Healthcare Limited0.620.0611.71%
NZ:TAHThird Age Health Services Limited3.86-1.74-31.12%
NZ:RUARua Bioscience Ltd.0.03-0.00-3.70%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 31, 2026